|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 19/00 | (2006.01) |
| C07K2319/30 | (2013.01) | ||
| A61K 38/16 | (2006.01) | ||
| A61K 38/00 | (2013.01) | ||
| A61K 38/45 | (2006.01) | ||
| C07K 14/70503 | (2013.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| C07K 14/705 | (2006.01) | ||
| A61P 35/02 | (2018.01) | ||
| C07K 16/00 | (2006.01) | ||
| A61P 43/00 | (2018.01) | ||
| C12N 15/62 | (2006.01) | ||
| A61K 38/00 | (2006.01) |
| (11) | Patento numeris | 3575326 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19185175.7 |
| Europos patento paraiškos padavimo data | 2013-12-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-12-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-04-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201261738008 P | 2012-12-17 | US |
| (72) |
UGER, Robert Adam , CA
SLAVOVA-PETROVA, Penka Slavtcheva , CA
PANG, Xinli , CA
|
| (73) |
Trillium Therapeutics ULC ,
2488 Dunwin Drive, Mississauga, Ontario L5L 1J9,
CA
|
| (54) | TREATMENT OF CD47+ DISEASE CELLS WITH SIRP ALPHA-FC FUSIONS |
| TREATMENT OF CD47+ DISEASE CELLS WITH SIRP ALPHA-FC FUSIONS |